Market Overview

Mizuho Securities Initiates Coverage on AcelRx Pharmaceuticals, Inc. at Buy, Announces $13.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS

Latest Ratings for ACRX

DateFirmActionFromTo
May 2016Seaport GlobalUpgradesAccumulateBuy
May 2016H.C. WainwrightMaintainsBuy
Oct 2015JefferiesAssumesBuy

View More Analyst Ratings for ACRX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (ACRX)